Shanafelt Armen 4
4 · Surface Oncology, Inc. · Filed Jun 6, 2019
Insider Transaction Report
Form 4
Shanafelt Armen
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2019-06-05+12,100→ 12,100 totalExercise: $3.69Exp: 2029-06-05→ Common Stock (12,100 underlying)
Footnotes (1)
- [F1]This option shall vest in full upon the earlier to occur of the first anniversary of the date of grant or the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director.